A Novel Attenuated NADC30-Like PRRSV Vaccine Candidate Provides Cross-Protection Against Homologous and Heterologous Viral Challenge.

Transbound Emerg Dis · 2026 · PMC13334135 · PMID 42402966

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Viral RNA levels in lung tissues were significantly elevated in both the mock (JXA1) and mock (AHFY‐F1) groups, measuring 10 9 · 6 copies/g and 10 7 · 0 copies/g, respectively, with a highly significant difference between these two groups ( p < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.